Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study
Saved in:
Main Authors: | Airi Fujimoto, Yoshimichi Koutake, Daisuke Hisamatsu, Noriko Ookubo, Yurika Yabuuchi, Go Kamimura, Tatsuo Kai, Aki Kozono, Takahiro Ootsu, Hiroto Suzuki, Keisuke Matsuo, Kimiko Kuwahara, Yoshita Oiwane, Yuko Nagata, Kenya Tanimoto, Eri Sato, Mei Suenaga, Tomohiro Uehara, Akira Ikari, Satoshi Endo, Yoichi Hiraki, Yosei Kawamata |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-12-01
|
Series: | Cancer Immunology, Immunotherapy |
Online Access: | https://doi.org/10.1007/s00262-024-03874-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune Tolerance Regulation Is Critical to Immune Homeostasis
by: Lei Han, et al.
Published: (2025-01-01) -
Powering the Immune System: Mitochondria in Immune Function and Deficiency
by: Melissa A. Walker, et al.
Published: (2014-01-01) -
Immune conversations at the border: meningeal immunity in health and disease
by: Preya U. Patel, et al.
Published: (2025-01-01) -
Immune infiltrate populations within distinct tumor immune microenvironments predictive of immune checkpoint treatment outcome
by: Brian Z Ring, et al.
Published: (2025-01-01) -
The Immune System /
by: Parham, Peter